{
    "clinical_study": {
        "@rank": "26744", 
        "arm_group": [
            {
                "arm_group_label": "Tramadol 1", 
                "arm_group_type": "Experimental", 
                "description": "1 mg/kg tramadol + 0.25% levobupivacaine 4 ml/h infusion"
            }, 
            {
                "arm_group_label": "Tramadol 2", 
                "arm_group_type": "Experimental", 
                "description": "2mg/kg tramadol + 0.25% levobupivacaine 4 ml/h infusion"
            }, 
            {
                "arm_group_label": "Levobupivacaine", 
                "arm_group_type": "Placebo Comparator", 
                "description": "0.25% levobupivacaine 4ml/h infusion"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients experience considerable amount of pain after cesarean section. The aim of this\n      study is to investigate the effect of tramadol (an opioid pain killer) added to\n      levobupivacaine (a local anesthetic) in continuous wound infusion (which is done by placing\n      a catheter in the incision) after cesarean sections."
        }, 
        "brief_title": "Usage of Tramadol With Levobupivacaine for Pain Treatment After Cesarean Section", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Postoperative Pain Following Cesarean Section", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Planned cesarean section\n\n          -  American Society of Anesthesiologists Class I-II\n\n        Exclusion Criteria:\n\n          -  Patients refusing to enroll in the study\n\n          -  Serious coagulopathy\n\n          -  Serious systemic disease\n\n          -  Story of allergy to drugs being used in the study\n\n          -  Morbid obesity (Body mass index > 30)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01916915", 
            "org_study_id": "09/06"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Tramadol 1", 
                    "Tramadol 2"
                ], 
                "intervention_name": "Tramadol infusion via wound catheter", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Tramadol 1", 
                    "Tramadol 2", 
                    "Levobupivacaine"
                ], 
                "intervention_name": "Levobupivacaine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Tramadol", 
                "Levobupivacaine", 
                "Bupivacaine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "August 5, 2013", 
        "location": {
            "contact": {
                "email": "erdogduperi@gmail.com", 
                "last_name": "Perihan Ekmek\u00e7i, MD", 
                "phone": "903122044000"
            }, 
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06520"
                }, 
                "name": "Ufuk University Dr R\u0131dvan Ege Hospital"
            }, 
            "investigator": {
                "last_name": "Gamze S \u00c7a\u011flar, Associate Professor", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Effect of Addition of Tramadol to Levobupivacaine in Continuous Wound Infusion for Postoperative Pain Treatment in Cesarean Section", 
        "overall_contact": {
            "email": "erdogduperi@gmail.com", 
            "last_name": "Perihan Ekmek\u00e7i", 
            "phone": "903122044000"
        }, 
        "overall_official": {
            "affiliation": "Ufuk University Dr R\u0131dvan Ege Hospital Department of Anesthesiology and Reanimation", 
            "last_name": "Perihan Ekmek\u00e7i, Associate Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "lowering of pain as measured by visual analogue scores", 
            "safety_issue": "No", 
            "time_frame": "forty eight hours after the operation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01916915"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ufuk University", 
            "investigator_full_name": "Perihan Ekmek\u00e7i", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "total additional analgesic consumption", 
            "safety_issue": "No", 
            "time_frame": "forty eight hours after the operation"
        }, 
        "source": "Ufuk University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ufuk University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}